Results 261 to 270 of about 73,785 (303)

Direct Oral Anticoagulants in Cirrhosis

Current Treatment Options in Gastroenterology, 2016
The risk of thrombosis in patients with chronic liver disease is increasingly recognized. As patients with cirrhosis develop indications for anticoagulation therapy (e.g., venous thromboembolism, portal vein thrombosis, or atrial fibrillation), providers are left to make difficult decisions when selecting therapeutics with little evidence to rely on ...
Nicolas M, Intagliata, Hillary, Maitland, Stephen H, Caldwell   +2 more
openaire   +2 more sources

Direct oral anticoagulants today

Medicina Clínica (English Edition), 2021
Carlos, Escobar Cervantes, Vivencio, Barrios Alonso   +1 more
openaire   +2 more sources

Direct Oral Anticoagulants

2015
Direct oral anticoagulants (DOACs) are rapidly changing the way we think about selecting, treating, and monitoring patients in need of anticoagulation. These agents may be used for either treatment or prophylaxis of systemic embolism and have been compared to vitamin K antagonist (e.g., warfarin) for many of the same indications.
openaire   +1 more source

Direct Oral Anticoagulation in Cancer Patients

2021
Thrombosis is a leading cause of mortality in cancer patients. Cancer patients are at an increased risk of developing atrial fibrillation, and venous thromboembolism is a leading cause of mortality, especially in patients undergoing chemotherapy. The anticoagulant strategy to be administered in these cases is particularly difficult to choose due to an ...
Bottino R., Carbone A., Liccardo B., D'Andrea A., Golino P., Nigro G., Russo V.   +6 more
openaire   +1 more source

Direct oral anticoagulants in hypercoagulable states

Journal of Thrombosis and Thrombolysis, 2016
Direct oral anticoagulants have been shown safe and effective in the treatment of pulmonary emboli and deep vein thrombi. Their role in the treatment of patients with hypercoagulability is uncertain. We designed a retrospective exploratory analysis of all patients with definite heparin induced thrombocytopenia (HIT) and antiphospholipid syndrome (APS ...
Paul R, Kunk, Jacqueline, Brown, Melissa, McShane, Surabhi, Palkimas, B, Gail Macik   +4 more
openaire   +2 more sources

[Anticoagulation-direct oral anticoagulants].

Der Internist, 2018
Since direct oral anticoagulants (DOAC) have become available, use of anticoagulant treatment has become easier and safer-for patients suffering from thromboembolic diseases as well as for patients with atrial fibrillation: Because of constant bioavailability, fixed dose regimen treatment is possible, monitoring not necessary and severe bleeding ...
openaire   +1 more source

Direct Oral Anticoagulants in Atrial Fibrillation

Seminars in Hematology, 2014
Atrial fibrillation (AF), the most frequent sustained arrhythmia, is associated with an increased risk of thromboembolic events. The risk of stroke depends on risk factors such as age, hypertension, heart failure, and vascular disease. Thus, antithrombotic therapy is a cornerstone in the management of AF.
Georg, Noll, Sarah, Noll, David, Hürlimann   +2 more
openaire   +2 more sources

Direct oral anticoagulant medications in calciphylaxis

International Journal of Dermatology, 2017
AbstractBackgroundRecent studies suggest that calciphylaxis is a thrombotic condition in which arteriolar thrombosis leads to painful skin infarcts and consequent morbidity and mortality. Paradoxically, warfarin is implicated as a risk factor for calciphylaxis.
Brian J, King, Rokea A, El-Azhary, Marian T, McEvoy, Raymond C, Shields, Robert D, McBane, James T, McCarthy, Mark D P, Davis   +6 more
openaire   +2 more sources

Direct Oral Anticoagulants in Cancer Patients

Seminars in Thrombosis and Hemostasis, 2019
AbstractCancer-associated thrombosis (CAT) is a common occurrence in the journey of a cancer patient and its management poses significant challenges. Low molecular weight heparin (LMWH) is the standard of care but the high cost and the inconvenience of daily injections have led to low persistence with therapy.
Deepa, Suryanarayan, Agnes Y Y, Lee, Cynthia, Wu   +2 more
openaire   +2 more sources

Direct oral anticoagulants in trauma patients

Current Opinion in Anaesthesiology
Purpose of review Direct oral anticoagulants (DOACs) are increasingly prescribed for prevention of thromboembolic events. Thus, trauma care providers are facing a steadily raising number of injured patients on DOACs. Recent findings Despite a predictable pharmacokinetic profile, the
Herbert, Schöchl, Oliver, Grottke, Felix C F, Schmitt   +2 more
openaire   +2 more sources